Akbar Indo Makmur Stimec Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Akbar Indo Makmur Stimec Tbk trades at Rp384 (market cap 86.24B, 288.2K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 3.7× Akbar Indo Makmur Stimec Tbk's market cap, and Akbar Indo Makmur Stimec Tbk is more actively traded (288.2K versus 41.7K). Which is the better fit depends on your goals.
| AIMS | DGNS | |
|---|---|---|
Market Cap | 86.24B | 316.25B |
Volume | 288.2K | 41.7K |
Lot | 2.88K | 417 |
Turnover | 112.41M | 9.66M |
Average Price | 390.06 | 231.65 |
Value | 112.41M | 9.66M |
Indicative Equilibrium Price | 384 | 230 |
Indicative Equilibrium Volume | 30 | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Akbar Indo Makmur Tbk was established on May 7th 1997. On November 17th, 2000, PT. Stimec merged by PT. Akbar Indo Makmur and changed to be PT. Akbar Indo Makmur Stimec.
Read more on AIMS →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →